INDICATORS OF HEPATOPULMONAINDICATORS OF HEPATOPULMONARY SYNDROME IN PATIENTS WITH PORTAL HYPERTENSION
AbstractBackground: Hepatopulmonary syndrome is severe pulmonary vascular complication of chronic liver disease requiring liver transplant. This study was conducted to evaluate different indicators of HPS in patients with portal hypertension, its varied aetiologies, clinical features & outcome. Methods: Hospital based descriptive study, 203 patients were enrolled, divided in to 2 groups positive and negative on the basis of presence or absence of HPS as per diagnostic criteria. Results: It included 203 patients with portal Hypertension of varied aetiologies. Age range was 8.76±3.69 years. 54.7% were male & 45.3% female. Commonest diagnosis for portal hypertension was portal vein thrombosis in 48 (23.6%) while Least common was biliary atresia seen in 6 (3%) of cases. Fifteen patients were included in Positive group and 188 in negative group. Clinical & laboratory parameters in order of frequency in positive group were hypoxia & cyanosis in 100% & 93.3% followed by dyspnoea & grade 4 clubbing in 86.6% patients (p<0.001). Child scoring was also done in all patients. In negative group 7 (3.7%) had dyspnoea, I (0.53%) had grade 4 clubbing while none showed evidence of hypoxia or cyanosis (p<0.001). Three patients underwent a successful liver transplant. One patient of biliary atresia & another of CHF expired. Conclusion: In All children with CLD and/or PHT with unexplained dyspnoea, cyanosis and grade 4 clubbing, HPS should be suspected. It is an indication for early LT even in absence of liver failure. Keywords: Hepatopulmonary syndrome; Arterial oxygen tension; PaO2; Alveolar-arterial oxygen gradient O2 gradient; contrast-enhanced echocardiography; CEE; technetium-99m Macro aggregated Albumin; 99 mTc-MAA, Liver Transplant
I. Grilo-Bensusan and J. M. Pascasio-Acevedo, “Hepatopulmonary syndrome: What we know and what we would like to know,” World Journal of Gastroenterology 2016, vol. 22, no. 25, pp. 5728–5741.
V. Ho, “Current concepts in the management of hepatopulmonary syndrome,” Vascular Health and RiskManagement 2008, vol. 4, no. 5, pp. 1035–1041.
Zhang J, Luo B, Tang L, Wang Y, Stockard CR, Kadish I, et al. Pulmonaryangiogenesis in a rat model of hepatopulmonary syndrome. Gastroenterology 2009;136:1070–1080.
J. S. Fritz, M. B. Fallon, and S. M. Kawut, “Pulmonary vascular complications of liver disease,” American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 2, pp. 133–143, 2013
Arguedas MR, Singh H, Faulk DK, Fallon MB. Utility of pulse oximetry screening for hepatopulmonary syndrome. Clin GastroenterolHepatol 2007;5:749–754.
Sasaki T, Hasegawa T, Kimura T, Okada A, Mushiake S, Matsushita T. Development of intrapulmonary arteriovenous shunting in postoperative biliary atresia: evaluation by contrast-enhanced echocardiography. J Pediatr Surg 2000; 35: 1647-50.
Noli K, Solomon M, Golding F, Charron M, Ling SC. Prevalence of hepatopulmonary syndrome in children. Pediatrics 2008; 121: 522-7.
Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995; 109: 1283-8.
Cosarderelioglu C, CosarAM ,Gurakar M, Dagher N &Ahmet, Gurakar A. Hepatopulmonary Syndrome and Liver Transplantation:A Recent Review of the Literature. Journal of Clinical and Translational Hepatology 2016 vol. 4 | 47–53).
Rodriguez-Roisin, R, Krowka MJ, Hepatopulmonry syndrome: a liver–induced lung vascular disorder. N Eng J Med 2008; 358: 2378-2387.
Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology 2005;41:1122– 1129.
Singh C, Sager JS. Pulmonary complications of cirrhosis. Med Clin North Am 2009;93:871–883
Fallon MB, Krowka MJ, Brown RS, Trotter JF, Zacks S, Roberts KE, et al. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology 2008; 135: 1168-1175.
Fuhrmann V, Madl C, Mueller C, Holzinger U, Kitzberger R, Funk GC, et al. Hepatopulmonary syndrome in patients with hypoxic hepatitis. Gastroenterology 2006;131:69–75
De BK, Sen S, Biswas PK, Sanyal R, Majumdar D, Biswas J. Hepatopulmonary syndrome in inferior vena cava obstruction responding to cavoplasty. Gastroenterology 2000;118:192–196.
Marti´nezPalli G, Barberà JA, Visa J, et al. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol 2001; 34: 651-7
Krowka MJ, Dickson R, Wiesner RH, et al. A prospective study of pulmonary function and gas exchange following liver transplantation. Chest 1992; 102: 1161-6.
Gupta S, Castel H, Rao RV, Picard M, Lilly L, Faughnan ME, et al. Improved survival after liver transplantation in patients with hepatopulmonary syndrome. Am J Transplant 2010;10:354–363.
Kochar R, Tanikella R, Fallon MB. Serial pulse oximetry in hepatopulmonary syndrome. Dig Dis Sci 2011;56:1862–1868.
Kliegman R M, Stanton B F, St Gene, Schor N F.Nelson Textbook Of Pediatrics: Behrman R E:ELSEVIER; 2015
D. Erge, M. A. Selimo˘glu, C. Karakurt et al., “Report of seven children with hepatopulmonary syndrome,” Turkish Journal of Gastroenterology, vol. 25, no. 6, pp. 724–729, 2014.
Krowka MJ, Mandell MS, Ramsay MA, et al. Hepatopulmonary syndrome and portopulmonary hypertension: A report of the multicenter liver transplant database. Liver Transpl 2004; 10:174-82.
W. De Jesus-Rojas, K. McBeth, A. Yadav, J. M. Stark, R. A. Mosquera, and C. Jon. Severe Hepatopulmonary Syndrome in a Child with Caroli Syndrome. Hindawi Case Reports in PediatricsVolume 2017, Article ID 2171974, 4 pages
Schenk P, Schoniger-Hekele M, Fuhrmann V, et al. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003; 125: 1042-52
Battaglia SE, Pretto JJ, Irving LB, et al. Resolution of gas exchange abnormalities and intrapulmonary shunting following liver transplantation. Hepatology 1997; 25: 1228-32.
Tiao GM, Alonso MH, Ryckman FC. Pediatric liver transplantation. Sem Pediatr Surg 2006; 15: 218-27.
Al-Hussaini A, Taylor RM, Samyn M, et al. Long-term outcome and management of hepatopulmonary syndrome in children. Pediatr Transplant 2010; 14: 276-82.
Fleming GM. Cornell TT. Welling TH. Magee JC. Annich GM Hepatopulmonary syndrome: Use of extracorporeal life support for life-threatening hypoxiafollowing liver transplantation. Liver Transplant 2008; 14(7):966-970.
Herve P, Le Pavec J, Sztrymf B, Decante B, Savale L, Stibon O. Pulmonary vascular abnormalities in cirrhosis. Best Pract Res Clin Gastroenterol 2007; 21:141–159
De BK, Dutta D, Pal SK, Gangopadhyay S, Das Baksi S, Pani A. The role of garlic in hepatopulmonary syndrome: a randomized controlled trial. Can JGastroenterol 2010;24:183–188.
Horvatits T, Drolz A, Roedl K, Herkner H, Ferlitsch A, Perkmann T, et al. Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosis. J Hepatol 2014;61:544–549.